ESMO 2023: Everolimus Improves Recurrence-Free Survival in Subgroup of Patients With RCC
Treatment improved survival in patients with clear-cell RCC at high risk for recurrence
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.